AAPL   314.69 (-0.64%)
MSFT   178.66 (-1.60%)
FB   224.83 (-3.17%)
GOOGL   1,405.22 (-1.14%)
AMZN   2,375.48 (-1.92%)
NVDA   329.47 (-5.52%)
MU   44.53 (-2.77%)
GE   7.33 (+7.80%)
TSLA   806.99 (-1.45%)
AMD   50.52 (-5.02%)
T   31.88 (+3.41%)
F   6.02 (+2.91%)
GILD   73.50 (+0.44%)
DIS   121.07 (+0.10%)
BAC   25.45 (+4.82%)
BA   145.48 (+0.52%)
AAPL   314.69 (-0.64%)
MSFT   178.66 (-1.60%)
FB   224.83 (-3.17%)
GOOGL   1,405.22 (-1.14%)
AMZN   2,375.48 (-1.92%)
NVDA   329.47 (-5.52%)
MU   44.53 (-2.77%)
GE   7.33 (+7.80%)
TSLA   806.99 (-1.45%)
AMD   50.52 (-5.02%)
T   31.88 (+3.41%)
F   6.02 (+2.91%)
GILD   73.50 (+0.44%)
DIS   121.07 (+0.10%)
BAC   25.45 (+4.82%)
BA   145.48 (+0.52%)
AAPL   314.69 (-0.64%)
MSFT   178.66 (-1.60%)
FB   224.83 (-3.17%)
GOOGL   1,405.22 (-1.14%)
AMZN   2,375.48 (-1.92%)
NVDA   329.47 (-5.52%)
MU   44.53 (-2.77%)
GE   7.33 (+7.80%)
TSLA   806.99 (-1.45%)
AMD   50.52 (-5.02%)
T   31.88 (+3.41%)
F   6.02 (+2.91%)
GILD   73.50 (+0.44%)
DIS   121.07 (+0.10%)
BAC   25.45 (+4.82%)
BA   145.48 (+0.52%)
AAPL   314.69 (-0.64%)
MSFT   178.66 (-1.60%)
FB   224.83 (-3.17%)
GOOGL   1,405.22 (-1.14%)
AMZN   2,375.48 (-1.92%)
NVDA   329.47 (-5.52%)
MU   44.53 (-2.77%)
GE   7.33 (+7.80%)
TSLA   806.99 (-1.45%)
AMD   50.52 (-5.02%)
T   31.88 (+3.41%)
F   6.02 (+2.91%)
GILD   73.50 (+0.44%)
DIS   121.07 (+0.10%)
BAC   25.45 (+4.82%)
BA   145.48 (+0.52%)
Log in

NASDAQ:CRSPCrispr Therapeutics Insider Trades

$61.30
-5.04 (-7.60 %)
(As of 05/27/2020 11:51 AM ET)
Add
Compare
Today's Range
$59.89
Now: $61.30
$66.59
50-Day Range
$39.38
MA: $53.97
$69.94
52-Week Range
$32.30
Now: $61.30
$74.00
Volume59,594 shs
Average Volume997,819 shs
Market Capitalization$3.74 billion
P/E Ratio81.73
Dividend YieldN/A
Beta2.26

Insider Trades

Crispr Therapeutics (NASDAQ:CRSP) Insider Buying and Selling Activity

Insider Ownership Percentage: 17.10%

Insider Buying and Selling by Quarter


Crispr Therapeutics (NASDAQ CRSP) Insider Trading History

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
5/20/2020Samarth KulkarniCEOSell10,693$65.28$698,039.04175,833  
5/19/2020Rodger NovakPresidentSell50,000$65.00$3,250,000.00798,007  
5/11/2020Lawrence Otto KleinCOOSell25,000$60.40$1,510,000.0045,000  
11/19/2019Pablo J CagnoniDirectorSell7,500$62.00$465,000.007,500  
11/19/2019Rodger NovakPresidentSell33,618$70.00$2,353,260.0033,618  
11/12/2019Pablo J CagnoniDirectorSell7,500$55.00$412,500.007,500  
10/30/2019Pablo J CagnoniDirectorSell7,500$52.00$390,000.007,500  
7/11/2019Lawrence Otto KleinInsiderSell20,000$50.02$1,000,400.0031,579  
7/10/2019Rodger NovakPresidentSell50,000$50.00$2,500,000.00848,007  
6/17/2019Samarth KulkarniCEOSell20,000$46.00$920,000.00185,801  
6/10/2019Rodger NovakPresidentSell50,000$45.00$2,250,000.00898,007  
4/29/2019Samarth KulkarniCEOSell20,000$42.03$840,600.00186,542  
3/4/2019Rodger NovakPresidentSell85,220$40.40$3,442,888.001,024,534  
3/1/2019Rodger NovakPresidentSell8,693$40.01$347,806.931,024,534  
2/25/2019Rodger NovakPresidentSell14,780$40.00$591,200.001,033,227  
1/8/2019Rodger NovakPresidentSell17,310$35.09$607,407.901,130,697  
12/27/2018Vertex Pharmaceuticals (EuropeMajor ShareholderBuy40,198$24.93$1,002,136.14  
12/24/2018Vertex Pharmaceuticals (EuropeMajor ShareholderBuy90,742$24.08$2,185,067.36  
12/21/2018Vertex Pharmaceuticals (EuropeMajor ShareholderBuy22,742$22.58$513,514.36  
12/18/2018Kurt Von EmsterDirectorSell72,934$29.85$2,177,079.90  
7/5/2018Pablo J CagnoniDirectorSell7,500$62.00$465,000.005,816  
7/3/2018Pablo J CagnoniDirectorSell5,816$62.00$360,592.005,816  
6/5/2018Kurt Von EmsterDirectorSell920$12.51$11,509.2090,000  
6/1/2018Samarth KulkarniCEOSell15,000$69.36$1,040,400.00163,560  
5/17/2018Rodger NovakPresidentSell75,000$60.00$4,500,000.001,183,247  
5/14/2018Kurt Von EmsterDirectorSell650,000$54.39$35,353,500.005,629  
5/11/2018Kurt Von EmsterDirectorSell250,000$52.84$13,210,000.00  
5/8/2018Bradley J Phd BolzonDirectorSell128,950$50.39$6,497,790.5037,645  
4/30/2018Bradley J Phd BolzonDirectorSell30,566$50.29$1,537,164.1443,986  
4/27/2018Thomas WoiwodeDirectorSell222,258$50.11$11,137,348.38  
4/24/2018Versant Venture Capital V, L.PMajor ShareholderSell22,841$50.99$1,164,662.59  
4/23/2018Bradley J Phd BolzonDirectorSell101,994$50.68$5,169,055.9243,986  
1/16/2018Tyler Dylan-HydeInsiderSell66,000$28.03$1,849,980.0025,204  
1/5/2018Aktiengesellschaft BayerMajor ShareholderBuy527,472$22.75$11,999,988.00  
1/5/2018Kurt Von EmsterDirectorSell92,337$26.96$2,489,405.52  
1/2/2018Kurt Von EmsterDirectorSell37,754$26.76$1,010,297.04  
1/2/2018Tyler Dylan-HydeInsiderSell38,000$21.64$822,320.0070,204  
12/29/2017Tyler Dylan-HydeInsiderSell31,000$22.72$704,320.00  
12/28/2017Tyler Dylan-HydeInsiderSell700$21.75$15,225.00115,904  
12/22/2017Thomas WoiwodeDirectorSell3,059$20.29$62,067.114,959  
12/22/2017Tyler Dylan-HydeInsiderSell15,000$20.55$308,250.00115,204  
12/15/2017Tyler Dylan-HydeInsiderSell15,000$18.90$283,500.00130,204  
12/4/2017Corp /De/ CelgeneMajor ShareholderSell1,112,446$18.98$21,114,225.08  
12/1/2017Corp /De/ CelgeneMajor ShareholderSell87,991$19.10$1,680,628.10  
11/29/2017Corp /De/ CelgeneMajor ShareholderSell4,263$19.25$82,062.75  
11/27/2017Corp /De/ CelgeneMajor ShareholderSell27,990$19.75$552,802.50  
11/27/2017Thomas WoiwodeDirectorSell200$20.24$4,048.008,218  
11/24/2017Corp /De/ CelgeneMajor ShareholderSell26,010$20.00$520,200.00  
11/24/2017Thomas WoiwodeDirectorSell1,700$20.21$34,357.008,218  
11/22/2017Corp /De/ CelgeneMajor ShareholderSell256,000$19.76$5,058,560.00  
11/20/2017Corp /De/ CelgeneMajor ShareholderSell158,718$19.02$3,018,816.36  
11/17/2017Corp /De/ CelgeneMajor ShareholderSell51,282$18.44$945,640.08  
11/15/2017Corp /De/ CelgeneMajor ShareholderSell15,000$17.67$265,050.00  
11/13/2017Corp /De/ CelgeneMajor ShareholderSell65,093$17.76$1,156,051.68  
11/10/2017Corp /De/ CelgeneMajor ShareholderSell10,000$17.28$172,800.00  
11/8/2017Corp /De/ CelgeneMajor ShareholderSell16,875$18.06$304,762.50  
11/6/2017Corp /De/ CelgeneMajor ShareholderSell79,327$18.89$1,498,487.03  
11/3/2017Corp /De/ CelgeneMajor ShareholderSell22,759$19.10$434,696.90  
9/5/2017Rodger NovakCEOSell18,470$20.76$383,437.201,148,007  
8/30/2017Rodger NovakCEOSell75,795$20.25$1,534,848.751,232,697  
8/30/2017Samarth KulkarniInsiderSell27,154$20.08$545,252.32110,893  
8/28/2017Kurt Von EmsterDirectorSell88,011$19.79$1,741,737.69  
8/25/2017Kurt Von EmsterDirectorSell22,781$19.42$442,407.02  
8/23/2017Kurt Von EmsterDirectorSell17,989$18.53$333,336.17  
8/21/2017Kurt Von EmsterDirectorSell3,150$18.52$58,338.00  
8/17/2017Kurt Von EmsterDirectorSell34,141$19.06$650,727.46  
8/15/2017Kurt Von EmsterDirectorSell55,569$19.59$1,088,596.71  
8/8/2017Kurt Von EmsterDirectorSell35,473$18.63$660,861.99  
8/8/2017Tyler Dylan-HydeInsiderSell15,000$18.57$278,550.00167,727  
8/4/2017Kurt Von EmsterDirectorSell50,477$17.81$898,995.37  
8/1/2017Kurt Von EmsterDirectorSell5,512$17.51$96,515.12  
7/28/2017Kurt Von EmsterDirectorSell41,312$17.63$728,330.56  
7/26/2017Kurt Von EmsterDirectorSell32,930$17.60$579,568.00  
7/14/2017Kurt Von EmsterDirectorSell69,859$16.84$1,176,425.56  
7/12/2017Kurt Von EmsterDirectorSell31,992$16.56$529,787.52  
7/5/2017Kurt Von EmsterDirectorSell4,254$16.26$69,170.04  
6/29/2017Kurt Von EmsterDirectorSell43,202$16.90$730,113.80  
6/27/2017Kurt Von EmsterDirectorSell81,435$17.08$1,390,909.80  
6/23/2017Kurt Von EmsterDirectorSell32,368$16.23$525,332.64  
6/22/2017Rodger NovakCEOSell10,825$15.37$166,380.251,225,830  
6/21/2017Rodger NovakCEOSell30,222$15.01$453,632.221,230,397  
6/9/2017Rodger NovakCEOSell5,303$15.02$79,651.061,219,208  
5/30/2017Rodger NovakCEOSell3,650$15.02$54,823.001,218,655  
5/17/2017Rodger NovakCEOSell50,000$16.26$813,000.001,239,082  
5/5/2017Rodger NovakCEOSell616$16.92$10,422.721,215,621  
5/4/2017Rodger NovakCEOSell49,384$16.30$804,959.201,230,929  
4/28/2017Tyler Dylan-HydeInsiderSell21,639$16.78$363,102.42180,495  
4/27/2017Samarth KulkarniInsiderSell5,481$16.76$91,861.56137,322  
4/25/2017Samarth KulkarniInsiderSell11,615$16.78$194,899.70137,047  
4/20/2017Rodger NovakCEOSell50,000$17.88$894,000.001,262,711  
4/20/2017Tyler Dylan-HydeInsiderSell10,177$17.71$180,234.67200,274  
10/24/2016Corp /De/ CelgeneMajor ShareholderBuy800,150$14.00$11,202,100.00  
10/24/2016Simeon GeorgeDirectorBuy66,500$14.00$931,000.00  
(Data available from 1/1/2013 forward)
This page was last updated on 5/27/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.